ArticleBMC medicine2025
Proinflammatory state and metabolic dysregulation linking delayed feeding progression to extrauterine restricted head growth in extremely preterm infants.
Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundGrowth of head circumference is critically associated with neurodevelopmental outcomes. Extrauterine growth restriction of head circumference from birth to term-equivalent age is linked to impaired neurodevelopment. This study examined whether a proinflammatory state and metabolic dysregulation characterize the association between delayed feeding progression and extrauterine restricted head growth in extremely preterm infants.
methodsThis cohort study included infants born ≤ 28 weeks' gestation between 2019 and 2021. Feeding progression trajectories, categorized as improvement or delayed improvement based on daily enteral feeding milk volumes during the first 8 weeks, were analyzed using kmlShape. Plasma metabolomics were assessed at 36 weeks postmenstrual age, and head growth and brain MRI were evaluated at term-equivalent age.
resultsAmong the 98 extremely preterm infants, 62 (63%) demonstrated improvement in feeding progression, while 36 (37%) had delayed improvement. Compared to the feeding improvement group, the delayed feeding improvement group had higher rates of gastrointestinal morbidities, including necrotizing enterocolitis (NEC) of Bell stage II or higher (17% vs. 2%, p = 0.009) and abdominal surgery for non-NEC events (25% vs. 8%, p = 0.021) during admission, and a significantly increased risk of extrauterine growth restriction in head circumference by term-equivalent age (47% vs. 23%, p = 0.021). The multivariable analysis showed delayed feeding improvement was also a significant risk associated with the delta z-scores below - 1.5 in head circumference (adjusted odds ratio [aOR]: 5.26 [95% CI 1.66-16.65]). MRI examinations revealed significantly smaller residual brain volumes involving total brain tissue volume, brainstem, and cerebellum in the delayed improvement group. Untargeted plasma metabolomics showed elevated levels of hydroxyeicosatetraenoic acid, leukotriene B4, prostaglandins, bile acids and immune markers, and reduced levels of L-tyrosine, phenylpyruvic acid, L-tryptophan metabolism, and L-carnitine biosynthesis were found in the delayed improvement group compared to that in the improvement group.
conclusionsProinflammatory and dysregulated metabolic state following early delayed feeding progression were associated with impaired extrauterine head growth, highlighting the potential role of the immature gut-brain axis in preterm infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.